& Hinton (1968), we found that women whose breast lumps were subsequently shown to be malignant delayed medical consultation far longer than those with benign lumps. By comparison with non-delayers, the patients who delayed seeking medical help were more likely to be post-menopausal, to regard their breast lumps as 'definitely not serious', to be deniers in the face of life crises, and to present to the doctor indirectly with symptoms other than breast symptoms.
Ignorance was rarely a cause of delay. Far more commonly, the main contributory factors appeared to be fear of cancer together with a fatalistic attitude towards outcome, or fear of losing the breast. The possibilities of either more limited surgery, or, alternatively, reconstructive surgery at some stage, deserve serious consideration. In order to counteract the extreme fear of cancer and fatalism about outcome which so often lead to delay, it will be necessary-as Aitken-Swan & Paterson (1955) and Easson (1970) have pointed outto alter the prevailing climate of opinion about cancer by abandoning the policy of medical silence in favour of frank discussion with patients and their husbands (apart, of course, from individual exceptions based on clinical judgment). Finally, it was discovered that diagnostic errors and deficiencies in administrative channels of communication also contributed to delay. It should not be beyond the wit of man to raise the standards of medical education to the point where women with painless, persisting breast lumps are no longer treated with reassurance or antibiotics but referred at once to the surgeon. Furthermore, a foolproof system must be devised to ensure that these patients are then admitted to hospital rapidly for diagnosis and treatment. Relevance It has become increasingly fashionable in Britain to condemn outright the traditional radical mastectomy which for some seventy years was the generally accepted treatment for carcinoma of the breast. Its use has been replaced to a large extent by simple mastectomy, with or without postoperative irradiation. Many centres throughout Britain, and some from abroad, have joined the King's College Hospital/Cambridge Trial in an admirable and completely justifiable attempt to assess the effect of radiotherapy on possibly involved axillary and internal mammary nodes in patients with Stage 1 or Stage 2 cancer of the breast, treated by simple mastectomy. The number of patients entered into this trial is by now probably sufficient to satisfy statisticians but it is as yet too early for any significant conclusions to be drawn. However, at least one fact does seem to have emerged, namely that we do not really know what we mean when we talk about an 'early carcinoma'.
In defence of the orthodox radical mastectomy, it is appropriate to say at this time that, in terms of overall long-term survival, no form of surgery has given us better results for 'early carcinoma'. Its performance requires real surgical skill, but when it is carried out with the necessary expertise and with careful attention to detail, mortality is negligible and morbidity minimal. Some patients are comforted by the thought that 'it has all been removed'; improved prostheses now available help patients to overcome the loss of the breast.
There is very little to recommend the so-called simple mastectomy. Because of the mistaken impression that it is a simple operation, it is often delegated to junior surgeons. Under these circumstances the main objective, which is to remove all breast tissue, may not be achieved. There is a significant incidence of hkmatoma formation, wound infection, skin edge necrosis, with resultant ugly scars, but the worst feature is the sacrifice of a whole breast. There is in fact little to choose between the mutilation of a simple mastectomy and that of a well-performed radical mastectomy. It is doubtful whether there is any difference in quality of life because it is the loss of the breast which is, to most women, the dreaded mutilation. Because of the biological factors hidden in any statistical analysis of a large series, it is difficult to decide whether there is any significant difference in long-term survival.
If the main argument against the Halsted radical mastectomy is that it does not remove the internal mammary nodes, then it would be logical to perfect the technique of a more radical mastectomy. However, it is now being taught that there is no need to remove nodes, but that the whole breast should still be removed, because of the danger of multifocal cancer; the logical extension of this doctrine is that both breasts should be removed.
Evidence is accummulating that surgery less radical than removal of the whole breast, avoiding demoralizing mutilation, can offer good survival rates and certainly a better quality life. How little is enough? 'Lumpectomy', an ugly word, is clearly not enough; neither 'tumourectomy' nor 'tylectomy' is an acceptable alternative, so I would suggest 'partial mastectomy'. In order to do this it is essential to make an adequate skin incision, usually removing an ellipse of skin, mobilize the deep aspect of the affected part of the breast, working from the periphery, so that two fingers can be inserted deep to the breast and the tumour palpated between these and the thumb. With experience it is not difficult to carry out an adequate partial resection, well clear of the edges of the carcinoma. Some 25 years ago, encouraged by my radiotherapy colleague, Dr Rigby Jones, I started doing partial mastectomy for inner quadrant growths followed by a course of radiotherapy, the average maximum dose being 6000 rad given over nine weeks.
The early results for these' inner quadrant partial mastectomies were encouraging so we extended its use to outer quadrant growths and then even to centrally placed lesions, conserving the areola and nipple. Most of the patients had clinical Stage 1 or clinical Stage 2 cancers. The size of the tumour was considered of importance only in relation to the size of the breast. Age was not consciously taken into consideration as a factor, nor were we consciously influenced by the feel of the tumour. Patient preference did influence our decision in the majority of these early cases.
During the period 1950-64, 96 patients with clinical Stage 1 and Stage 2 cancers were treated by partial mastectomy and postoperative radiotherapy. During this same period 207 patients with Stage 1 and Stage 2 cancers had been treated in the same unit by radical mastectomy, but only those with confirmed node involvement were given postoperative irradiation. In 1970 Professor Leslie Wise completed a very careful review of these two groups of patients which had been treated in this way over the fifteen-year period. Professor Lauren Ackerman came to England and reviewed all the sections. The information obtained was submitted to very detailed statistical analysis and the results presented at the Annual Meeting of the American Surgical Association in March 1971 (Wise et al. 1971) . The main results can be summarized as follows:
(1) Accuracy ofclinical staging: Although all cases had been examined preoperatively by both the consultant radiotherapist and the consultant surgeon at the breast clinic, our observer error, when checked by the pathologist on the radically resected specimens, was in the order of 40%: 38 % clinically involved nodes were found on section to be free of growth; conversely, 41 % of clinically negative nodes were shown to be involved. Node involvement was unfortunately not checked by biopsy in the local excision group, but we have assumed the existence of a similar clinical observer error. This degree of clinical inaccuracy has been reported by previous workers, so, whenever comparing results based on clinical staging, it is necessary to remember this possible observer error and only limited conclusions can be drawn from any apparent differences in results between Stage I and Stage 2 groups in any published series, unless these are based on pathological staging.
(2) Age distribution: The age distribution in the two groups was found to be statistically similar.
(3) Situation ofthe tumour: There was a significant difference in the situation of the tumour; 60% of the locally excised group being in the inner quadrant whereas 66 % of the radical group were situated in the outer half of the breast. The reason for this difference is that, in the first few years, partial mastectomy was limited to inner quadrant cancers.
(4) Size: During the course of these years our clinical impression was that we were tending to advise partial mastectomy for smaller tumours so it was of great interest to find on analysis of these patients that there was no significant difference in the absolute size of the tumour in the two groups. In both groups, approximately one-third were less than 2 cm, one-third between 2 and 4 cm, and one-third were over 4 cm in diameter. In retrospect it was clear that we considered size of the tumour only in relation to the size of the breast.
(5) Histology: There was no significant difference in the distribution of the specific types of mammary cancer in the two groups but, in addition, the slides were reclassified with the border, the differentiation and lymphocytic response as the main criteria. On the basis of differentiation there was no significant statistical difference, although there was a slightly higher percentage of welldifferentiated growths in the radical group and a slightly higher percentage of undifferentiated ones in the local group. The incidence of lymphocytic response was similar in both groups, approximately only 250% of all growths showing a reasonable or good response. The border was classified as pushing, mixed or infiltrating, and here we found a statistically significant difference; 74 % of the radically resected specimens showed an infiltrating border as compared with 540% in the locally excised group. In retrospect it seems likely that we were unconsciously influenced in our choice of treatment by the feel of the edge of the tumour.
(6) Survival rates: These were statistically analysed by several methods, crude survival, the actuarial life-table Berkson-Gage method, and the more sophisticated Boag-Sampford-Wette method. Looking at the figures and at the various curves produced, a clinician might be excused for thinking that these show a better five-year survival for Stage 1 growths treated by partial mastectomy (approximately 95 % five-year survival compared with 80% for the radical group) but, statistically, we were assured that there is no significant difference between these two groups, both for clinical Stage 1 and Stage 2. The statisticians were prepared to go further and to tell us that on the basis of the confidence limits and the estimated ultimate survival rates they could refute statements which suggested that no treatment is effective for mammary cancer.
(7) Local recurrence: Nine out of the 96 patients treated by partial mastectomy developed local recurrence; two of these patients manifested widely disseminated disease soon after local excision of the primary growth and before any local recurrence could be found. Although both had been thought to be cases of early breast cancer before treatment, it is almost certain that both had widely disseminated disease before local excision of the primary growth. Both serve to illustrate that we cannot as yet diagnose 'early cancer' with any real degree of accuracy. In the majority of these patients who developed local recurrence, retrospective study of the sections showed that excision had been inadequate, emphasizing again that local excision should be a generous partial mastectomy. It was possible to treat nearly all these local recurrences by a further local excision, but one required a total mastectomy because the residual breast would have been too small, one was treated by radical mastectomy and oophorectomy because of enlarging axillary nodes, and one, a late recurrence, was treated by further radiotherapy. Both groups are still being followed up and, as is to be expected, disseminated disease is still being found after 10 and 15 years, but our clinical impression, not as yet supported by statistics, is that there is still no significant difference between the two groups.
(8) Cosmetic result: An adequate partial mastectomy, which may entail removal of more than half the breast, does produce a significant difference in the size of the two breasts, and radiotherapy causes a further decrease in the volume of the affected breast. However, the cosmetic result is pleasing in most cases and acceptable in all, even when at least half the breast has been removed; certainly a better looking residual breast than a mastectomy scar. No patient has expressed any disappointment at the decreased size and, rather surprisingly, no patient has yet asked for her breasts to be equalized by excision of a corresponding amount of tissue from the other side. However, bilateral partial mastectomy may need to be considered seriously as a primary procedure not only for cosmetic reasons, but because it would provide valuable information about the incidence of lobular carcinoma in the other breast.
In the discussion which followed presentation of this series to the American Surgical Association, perhaps the most relevant question posed was: 'Which was the important part of this combined treatmentwas it the local excision or was it the radiotherapy?' We do know that radiotherapy alone can destroy completely some large and histologically proven cancers of the breast. As to the value of partial mastectomy alone, I had decided that a 'wait and see' policy would be ethically justifiable and had used this in a small number of cases before joining the King's College Hospital/Cambridge Breast Trial. Having now made my contribution of simple mastectomy cases to the trial, I feel free to resume partial mastectomy. It is of interest to note that, in this published series, there was one patient who presented 15 years ago with bilateral primary breast cancer. The right side was treated by partial mastectomy followed by irradiation because the tumour was situated in the inner upper quadrant; the cancer in the left breast was slightly smaller and situated in the outer half and it was treated by partial mastectomy only. She remains well and free from recurrence 15 years later. This is an anecdotal case, but I believe the time has now come when we are ethically justified in planning a trial of partial mastectomy, with and without postoperative irradiation to the breast only, as an alternative to mastectomy. Experience during recent years has shown that both good local control and a surprisingly high percentage of five-year survivals can follow irradiation treatment of even locally advanced breast cancers. The essential factor, if good results are to be obtained, is adequatei.e. highdosage of radiation. At the same time, painful skin reactions in the large areas needing to be covered must be avoided. Supervoltage radiation can be used to spare the skin, provided there is not wide skin involvement. As this is commonly present in advanced cases, full skin dosage is often necessary. By means of a split-course technique painful reactions can be avoided, even with orthovoltage radiation to high dosage. The tolerance limit with continuous fractionation is around 4250 R over three weeks, but this failed to sterilize the tumour in nearly all cases so treated.
In 33 patients treated by two-part split-course to an average of 5300 R (at 250 kV) in 14 fractions over four weeks, with a four-week rest peiiod, local control by radiation alone was achieved in 13 cases. In 12 others the tumour became operable. Identifiable cancer cells were seen in all mastectomy specimens, but local recurrence followed in only 4 patients.
In 14 patients (all Stage T3 or T4) treated by three-part split-course, to average tumour dose of 7000 R in 16 fractions over five weeks plus two rest periods, the tumour was controlled locally in 8 patients throughout their subsequent history. No carcinoma cells were identifiable in 4 of these who later underwent mastectomy. In 4 other patients the tumours became operable, but had not been histologically sterilized.
Four patients survived for over five years; 2 are alive and well at eight years. Two patients survived 'three years; one, who survived two years, died from metastases without local recurrence.
In spite of high dosage, delivered by 250 kV X-rays, skin reactions were very mild in 6 cases, moderate in 6 and severe in only 2.
Miss M D Snelling (Meyerstein Institute ofRadiotherapy, The Middlesex Hospital, London WIN8AA)
Experiences ofFrench Radiotherapists [Abstract]
An account was given of work carried out by French radiologists -this has been reported by Dr Calle of the Fondation Curie and also by other radiotherapists in the press and at a symposium on the 'conservative' treatment of carcinoma of the breast (i.e. the treatment of carcinoma of the breast without mastectomy). These radiotherapists report excellent results of the treatment of TINo carcinoma by local excision followed by radiotherapy. A tumour dose of 8000 rad or more is given to the primary area at these centres while the normal glands receive a dose of 6000 or 7000 rad. The use of radiotherapy in more advanced cases was also describedthe most important critical local structure is the brachial plexus. Survival of T1 and early T2 cases at five years is reported as approximately 75% and local cure without mastectomy in about 60%. Failures were due almost always to metastases. Cosmetic results were excellent in at least one-half of the patients.
